Works matching IS 15228517 AND DT 2019 AND VI 21 AND IP 6
Results: 17
Updates in the management of intradural spinal cord tumors: a radiation oncology focus.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 707, doi. 10.1093/neuonc/noz014
- By:
- Publication type:
- Article
Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 809, doi. 10.1093/neuonc/noz041
- By:
- Publication type:
- Article
Targeted copy number analysis outperforms histologic grading in predicting patient survival for WHO grades II/III IDH-mutant astrocytomas.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 819, doi. 10.1093/neuonc/noz052
- By:
- Publication type:
- Article
Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 800, doi. 10.1093/neuonc/noz037
- By:
- Publication type:
- Article
Sustained imaging response and hearing preservation with low-dose bevacizumab in sporadic vestibular schwannoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 822, doi. 10.1093/neuonc/noz051
- By:
- Publication type:
- Article
REST-DRD2 mechanism impacts glioblastoma stem cell–mediated tumorigenesis.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 775, doi. 10.1093/neuonc/noz030
- By:
- Publication type:
- Article
TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 755, doi. 10.1093/neuonc/noz029
- By:
- Publication type:
- Article
novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 742, doi. 10.1093/neuonc/noz038
- By:
- Publication type:
- Article
non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 719, doi. 10.1093/neuonc/noy204
- By:
- Publication type:
- Article
NG2/CSPG4 in glioblastoma: about flexibility.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 697, doi. 10.1093/neuonc/noz055
- By:
- Publication type:
- Article
Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 730, doi. 10.1093/neuonc/noz015
- By:
- Publication type:
- Article
Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 786, doi. 10.1093/neuonc/noz053
- By:
- Publication type:
- Article
How to integrate immunotherapy into standard of care in glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 699, doi. 10.1093/neuonc/noz043
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 703, doi. 10.1093/neuonc/noz076
- By:
- Publication type:
- Article
Dose diversification in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 701, doi. 10.1093/neuonc/noz063
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 825, doi. 10.1093/neuonc/noz075
- Publication type:
- Article
Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 765, doi. 10.1093/neuonc/noz031
- By:
- Publication type:
- Article